Hyperliquid Strategies Inc and Sonnet BioTherapeutics Holdings, Inc. Announce Closing of Business Combination
Trading on The Nasdaq Capital Market under the ticker symbol “PURR”
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 08/21/25 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 08/13/25 | 10-Q | Quarterly report [Sections 13 or 15(d)] |
|
  |
33 |
| 08/01/25 | DRS | Draft Registration Statement |
|
498 | |
| 08/01/25 | 8-K | Current report |
|
|
5 |
| 07/25/25 | SCHEDULE 13G | Statement of Beneficial Ownership by Certain Investors |
|
6 | |
| 07/25/25 | 8-K | Current report |
|
|
2 |
| 07/18/25 | 8-K | Current report |
|
|
2 |
| 07/15/25 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 07/15/25 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 07/15/25 | 4 | Statement of changes in beneficial ownership of securities |
|
1 |
